Purple Biotech Achieves Toxicology Milestone Demonstrating an Expanded Therapeutic Window for CAPTN-3 Platform Tri-specific Antibody, IM1240

IM1240 demonstrated improved safety in a toxicology study at doses up to 300-fold higher than a non-capped comparator ...

A Look At Elecnor (BME:ENO) Valuation After Recent Share Price Pullback

Why Elecnor (BME:ENO) is on investors’ radar Elecnor (BME:ENO) has drawn fresh attention after recent share price moves, with ...

CG Oncology: 'Strong Buy' On Earlier Than Expected Completed Recruitment Cretostimogene

CG Oncology develops cretostimogene via rolling BLA, phase 3 PIVOT-006 data in 1H 2026, and $680M cash into 2028. Find out ...

‘Govt good at implementation, so new welfarism, infra took off. (Pvt investment) needs rule of law, not to weaponise state to target or favour’

Arvind Subramanian, former Chief Economic Advisor, and Devesh Kapur, Professor of South Asian Studies at Johns Hopkins ...